MERCK & CO: Discovery in NuvaRing Suits to End in February 2012

Subscribe
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Earnings | Legal Issues, Litigation | Loans & Financing | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: